Depersonalization-Derealization Disorder: Symptoms, Diagnosis, and Treatment
Author: Angela Bogdanova · Published: October 9, 2026 · Editorial Policy
Research cluster: Dissociation & Dissociative Disorders · Written by Artificial Sapiens
Depersonalization-derealization disorder (DPDR disorder) is a diagnosable dissociative disorder in which experiences of detachment from oneself, one's surroundings, or both are persistent or recurrent, occur with intact reality testing, and cause significant distress or impairment. A person may feel as if they are observing themselves from outside, moving through life automatically, or experiencing the world through a dreamlike veil while understanding that these impressions do not mean the world has literally changed. This distinction between how reality feels and what the person knows about reality is central to clinical assessment. The American Psychiatric Association and the Merck Manual Professional describe this characteristic presentation.
Brief depersonalization or derealization can occur in otherwise healthy people during exhaustion, acute stress, panic, sleep disruption, or after substance exposure. The clinical question is whether the experience forms a persistent or recurring, distressing syndrome that cannot be better explained by another condition. The diagnosis is established through clinical evaluation, including appropriate medical and psychiatric differential assessment, rather than through a single sensation, online checklist, brain scan, or questionnaire score. This guide examines the subjective experience, DSM-5-TR and ICD-11 frameworks, course, contributing factors, assessment, differential diagnosis, treatment evidence, practical responses, and recovery questions.
What Is Depersonalization-Derealization Disorder?
Depersonalization describes a sense of detachment from one's own mind, emotions, body, sensations, or actions. Someone might report that their voice sounds unfamiliar, their body feels distant, their emotional reactions seem muted, or they are observing their daily activities rather than participating in them. Derealization describes a changed subjective quality of the external world: a familiar room may feel artificial, distant, foggy, flattened, unusually vivid, or as though it appears behind glass. The person usually recognizes that their surroundings remain physically real. Either symptom can predominate, and both can occur together.
The disorder is a particular diagnostic pattern within the broad family of dissociative conditions. The WHO ICD-11 clinical diagnostic reference includes depersonalization-derealization disorder under code 6B66. In the United States, clinicians commonly use the DSM-5-TR diagnostic description for clinical formulation. Differences in classification language, coding, and clinical implementation do not change the need for careful assessment of the actual experiences, impairment, insight, and alternative explanations.
DPDR disorder also appears in scientific literature under the older names depersonalization disorder or depersonalization/derealization disorder. The abbreviation DPDR often refers informally to the symptoms, while some authors use DPD or DDD for the disorder. In an educational context it is helpful to say which meaning is intended: feeling unreal for a few minutes is a depersonalization or derealization experience; a diagnosed disorder requires a substantially fuller clinical evaluation.
What Depersonalization and Derealization Feel Like
Depersonalization can involve a striking mismatch between having an experience and feeling emotionally present within it. A person may recognize their reflection, remember personal facts, carry out conversations, and make decisions yet describe the whole process as strangely remote. Some report altered perceptions of the size or ownership of body parts, disconnection from touch or movement, diminished spontaneous emotion, or a sensation of acting on autopilot. Such language conveys subjective detachment; by itself it is not evidence that identity has split or that a person has lost conscious control of their actions.
Derealization often concerns the ordinary environment. Faces may seem unfamiliar despite being recognized, colors or sounds may feel strangely distant or intensified, distances may appear unusual, and surroundings may seem staged or dreamlike. These impressions can be upsetting because everyday places suddenly feel unfamiliar. A person may repeatedly check whether they are awake or whether other people feel real. In DPDR disorder, the individual generally knows these impressions are subjective alterations in experience rather than discoveries about the literal nature of the environment.
Some people find the emotional features more disruptive than the perceptual descriptions. They may know intellectually that they love their partner or care deeply about an event while feeling little emotional immediacy. Others experience persistent anxiety about the sensation itself, anticipatory fear that the next episode will happen in public, or exhaustion from monitoring every change in awareness. Clinical assessment explores whether these features reflect DPDR, depression, anxiety, medication effects, or several conditions interacting.
Common Symptoms and Patterns
Typical complaints include detachment from the body or inner speech, feeling like an outside observer, emotional or physical numbing, a robot-like quality to actions, foggy or dreamlike surroundings, unfamiliarity of familiar places, and subjective distortions of distance or time. An individual can have only self-related symptoms, only environment-related symptoms, or both. The Mayo Clinic clinical overview documents this variation and emphasizes that persistent symptoms can disrupt daily functioning.
The intensity and temporal pattern also vary. A brief episode may happen during an acute stress response, while a clinically concerning pattern can recur across days or persist for weeks, months, or longer. Some people experience fluctuations that are barely perceptible at one moment and overwhelming at another. Symptom duration by itself does not identify the diagnosis: an isolated episode, a symptom associated with panic or intoxication, and an independent dissociative disorder represent different clinical possibilities.
Concentration complaints can arise because the person is distracted by the experience, frightened by it, sleep deprived, or preoccupied with checking whether the world feels normal. Those difficulties should be described precisely rather than interpreted automatically as ADHD, neurological memory loss, or dissociative amnesia. People with DPDR typically retain continuity of identity and ordinary autobiographical memory; pronounced unexplained memory gaps or identity discontinuity prompt evaluation of other causes and sometimes other dissociative conditions.
When Does a Common Experience Become a Clinical Disorder?
The boundary rests on the complete clinical pattern, particularly recurrence or persistence, meaningful distress or impairment, intact reality testing, and the absence of a better explanatory condition. A short spell of feeling detached after poor sleep is not equivalent to months of intrusive unreality that undermines work, relationships, social participation, and the capacity to enjoy daily life. Clinicians examine whether symptoms occur only in specific contexts, whether there are symptom-free periods, and what consequences they have for ordinary activities.
Population estimates require caution because studies measure different things. In a systematic epidemiologic review, Hunter, Sierra, and David reported that transient depersonalization or derealization experiences were common, while standardized population studies of the more persistent syndrome yielded much lower estimates. Modern clinical overviews frequently cite roughly 1–2% for the disorder, but diagnostic methods, time windows, geographic samples, and definitions differ. A prevalence estimate does not provide the probability that an individual reader has DPDR.
A later systematic review of prevalence using standardized diagnostic assessments identified 23 studies and estimated that depersonalization-derealization disorder affected roughly 1% of general-population samples, while individual population estimates ranged from 0% to 1.9%. Higher estimates in psychiatric samples cannot be generalized to the public. The review also illustrates why clinical diagnosis, prevalence of transient symptoms, and self-report questionnaire thresholds must be distinguished when reporting population figures.
DSM-5-TR Diagnostic Criteria Explained
DSM-5-TR requires persistent or recurrent experiences of depersonalization, derealization, or both. During these experiences, reality testing remains intact: the person understands that the feeling of being detached or that the world is unreal represents an alteration of experience. The symptoms must produce clinically significant distress or impairment in important areas of functioning. They also must not be attributable to the physiological effects of a substance or another medical condition, and they must not be better explained by another mental disorder. The clinician makes this judgment through a broader assessment, as summarized in the Merck Manual Professional diagnostic overview.
The reality-testing criterion requires careful interviewing. People often say 'I feel as if nothing is real' while also explaining that they know the world has not disappeared. This is compatible with DPDR phenomenology. If an individual is convinced that other people have been replaced, that external reality is fundamentally fabricated in a literal and fixed way, or that a strongly held delusional explanation is true, the diagnostic approach must expand. Insight can also fluctuate or become harder to describe under severe anxiety, so the clinician assesses beliefs, perception, context, and behavior rather than interpreting a single dramatic phrase literally.
The exclusion and differential criteria matter as much as the positive symptoms. Feeling unreal during a panic attack, after cannabis use, during certain seizures, or within another disorder does not automatically establish a separate DPDR diagnosis. Conversely, a person can have DPDR disorder and also have anxiety or depression when the complete criteria for more than one condition are met. The goal of assessment is a coherent formulation of what is happening and why specific care is appropriate.
ICD-11 and DSM-5-TR: How the Diagnoses Relate
The World Health Organization's 2024 Clinical Descriptions and Diagnostic Requirements provides an international clinical framework for ICD-11, including depersonalization-derealization disorder (6B66). DSM-5-TR is a separate American Psychiatric Association classification. Both recognize a clinically important syndrome involving experiences of detachment or unreality, and clinicians should follow the system applicable in their setting. Diagnostic codes, groupings, and documentation conventions can vary by system without requiring a false one-to-one correspondence across every dissociative presentation.
ICD-11 recognizes additional dissociative categories that do not map perfectly onto the DSM structure. For readers seeking a broader taxonomy, the key point here is that DPDR disorder concerns self- or world-detachment with retained recognition that the experience is subjective. It should not be merged with dissociative identity disorder, dissociative amnesia, partial DID, or ICD-11 dissociative neurological symptom disorder simply because they share a classification family.
What Causes Depersonalization-Derealization Disorder?
No single cause has been established. Clinical reports and observational research associate DPDR experiences with intense stress, anxiety, panic, sleep loss, certain substance exposures, and adverse experiences, while some people cannot identify a clear precipitating event. Biological vulnerability, learning, patterns of emotional processing, attentional focus, and the response to frightening internal sensations may contribute in different combinations. Association is not proof that one factor is necessary or sufficient to produce the disorder. The Mayo Clinic review of symptoms and causes emphasizes this uncertainty.
Traumatic experiences are important to ask about sensitively because they can be relevant to an individual's history and formulation. However, DPDR symptoms do not prove an undisclosed traumatic event, and neither the absence nor the presence of autobiographical memories can serve as a trauma test. If posttraumatic stress symptoms dominate the presentation, clinicians also evaluate PTSD and its possible dissociative subtype. The disorder addressed in this article is the persistent or recurrent DPDR syndrome as its own primary clinical presentation.
Some people notice their first strong depersonalization or derealization experience during a panic attack, prolonged stress, or after using cannabis or another psychoactive substance. The experience may then become an object of constant monitoring. Fearful interpretations such as 'this must mean permanent brain damage' can increase attention to subtle changes in perception and intensify distress. This maintaining cycle is a plausible cognitive-behavioral formulation for some patients, rather than a universal causal explanation. The Hunter and colleagues CBT study investigated therapy targeting threatening interpretations, avoidance, safety behaviors, and symptom monitoring.
What Research Suggests About Brain and Psychological Mechanisms
Experimental studies have examined emotional reactivity, autonomic responses, attention, and brain systems implicated in self-processing and regulation of emotion. A 2024 systematic review of experimental research reported some evidence for reduced subjective responses to aversive stimuli and increased activity in neural systems associated with emotional regulation during certain tasks. Findings were inconsistent for autonomic responses, facial-expression processing, emotional memory, and aspects of self-reference.
These studies support research into emotional detachment and altered integration of perceptual, bodily, and affective experience. They do not establish a unique diagnostic brain signature, a single damaged circuit, or an imaging test for DPDR. Many studies have small samples, cross-sectional designs, medication exposure, and psychiatric comorbidity; tasks and analytic methods differ. A clinical diagnosis is therefore made from the person's history and assessed symptom pattern, supported by medical investigation when indicated, rather than from an MRI picture marketed as a definitive DPDR marker.
Researchers also study interoception—the perception and interpretation of internal bodily states—and the sense of embodiment. These are promising frameworks for understanding why a person can know their body belongs to them yet experience it as strangely distant. Such ideas remain models that must be tested against clinical observations and better-controlled studies. The field benefits from distinguishing the mechanisms of a transient dissociative state from those that sustain a disabling long-term condition.
How Clinicians Diagnose DPDR
Assessment usually begins with a detailed account of the first episode, its onset and context, the exact sensation, duration, recurrence, current severity, and effect on functioning. A clinician asks what the patient believes is happening during episodes, whether they can distinguish sensations from reality, and whether symptoms are accompanied by panic, mood changes, sleep disturbance, dissociative memory problems, hallucination-like experiences, or altered awareness. The language of experience is often metaphorical, so asking for specific examples is more informative than treating phrases such as 'I am outside my body' as literal claims.
A full clinical history includes medications, alcohol and other substances, recent intoxication or withdrawal, headaches, migraines, seizure-like symptoms, neurological disease, head injury, medical illnesses, sleep deprivation, and previous mental-health difficulties. Clinicians assess trauma history when relevant and ethically appropriate, with attention to the patient's comfort and without assuming a hidden memory or a predetermined explanation. Cultural and personal interpretations of detachment may affect the words people use and require thoughtful exploration.
Physical examination, laboratory testing, EEG, imaging, or specialist referral are guided by clinical indications rather than required for every person with depersonalization. New neurological symptoms, unexplained episodes of altered awareness, unusual onset after injury, or atypical cognitive changes can justify further medical assessment. The Mayo Clinic diagnostic guide describes physical, laboratory, and mental-health evaluations as possible parts of the diagnostic process.
Questionnaires and Screening: What They Can Tell You
The Cambridge Depersonalization Scale is a research and clinical self-report instrument designed to describe the frequency and duration of depersonalization experiences, originally over a six-month frame. Its development and validation study documented initial psychometric properties in selected diagnostic groups. It can help identify symptom patterns and track change, but no score can by itself establish that DSM-5-TR or ICD-11 requirements are fulfilled or that medical and psychiatric alternatives have been excluded.
More general dissociation questionnaires, including the Dissociative Experiences Scale, cover a wider symptom domain and cannot be treated as specific DPDR diagnostic tests. A response to an online question such as 'Do you feel unreal?' lacks crucial information about timing, beliefs, substance use, associated disorders, and impairment. A comprehensive 2025 systematic review of dissociation measurement tools found substantial diversity and uneven measurement quality across instruments. Clinician-administered interviewing remains essential when a diagnostic conclusion has important consequences.
Differential Diagnosis: Conditions That Can Resemble DPDR
The differential is central because feelings of disconnection occur across many disorders and medical situations. The first question is descriptive: is the main change in the subjective feeling of self and environment, in attention or memory, in conscious awareness, in mood, in fixed beliefs about reality, or in bodily and neurological function? Several processes may overlap. Effective clinical assessment makes room for more than one condition when the evidence supports comorbidity.
Panic attacks and anxiety disorders
Depersonalization or derealization may accompany the abrupt surge of fear and physical symptoms of a panic attack, such as palpitations, trembling, dizziness, shortness of breath, and fear of catastrophe. The clinician examines whether detachment is confined mainly to attacks, continues between them, or represents an independent persistent condition. Anxiety may intensify a DPDR syndrome without being its sole explanation. A panic-specific treatment plan and a DPDR-focused formulation address partly different problems.
Psychosis and schizophrenia-spectrum conditions
In the characteristic DPDR presentation, a person can identify the unreality as a feeling. A psychotic disorder may instead involve delusions, hallucinations, or impaired reality testing, assessed in a wider clinical context. One sentence about the world seeming artificial is not sufficient to distinguish them. Clinicians explore conviction, the ability to reconsider beliefs, other psychotic symptoms, behavior, and possible neurological or substance causes. Psychosis and dissociative symptoms can sometimes co-occur, which makes categorical self-diagnosis from a short online description unreliable.
Depression, emotional numbness, and obsessive preoccupation
Depression can involve anhedonia, emotional blunting, slowing, concentration difficulties, and a sense of disconnection. Obsessive-compulsive and anxiety symptoms can involve persistent checking, reassurance seeking, and repeated analysis of one's internal experience. DPDR may coexist with these difficulties. Diagnosis depends on the central symptom pattern and its clinical context, not on assuming emotional numbness or repetitive existential questioning belongs to only one disorder.
PTSD and the dissociative subtype of PTSD
PTSD is defined by its own trauma-related diagnostic requirements. Depersonalization and derealization can occur within the dissociative subtype of PTSD, but their presence does not by itself diagnose PTSD. When trauma-linked reexperiencing, avoidance, threat-related symptoms, and other required features are central, PTSD assessment takes priority. The already published Dissociative Subtype of PTSD: Depersonalization, Derealization, and Assessment addresses that separate diagnostic intent.
Substance- or medication-related symptoms
Cannabis, hallucinogens, ketamine, certain other substances, and medication reactions can be associated with depersonalization or derealization. Timing matters: clinicians ask whether symptoms began during use, intoxication, withdrawal, a dosage change, or a period of multiple overlapping stressors. A symptom starting after substance exposure should be medically assessed on its own facts rather than being immediately classified as a lifelong primary dissociative disorder. Do not abruptly stop prescribed medication; discuss possible adverse effects and safe adjustments with the prescriber.
Seizures, migraine, and other medical or neurological causes
Focal seizures, migraine phenomena, altered sleep-wake states, neurological disorders, and some systemic conditions can produce experiences that overlap superficially with detachment. Episodes with loss of awareness, automatisms, injuries, sudden confusion, new severe headache, fainting, or focal neurological signs demand an appropriate medical evaluation. A history of depersonalization does not license an assumption that every new neurological symptom is psychological.
ADHD, dissociative amnesia, DID, and functional neurological symptoms
Attention lapses in ADHD, ordinary absentmindedness, and memory failures arising from fatigue differ from the defining subjective detachment and reality-testing features of DPDR. Dissociative amnesia concerns important autobiographical memory loss that requires a separate evaluation. Dissociative identity disorder concerns identity disruption and discontinuity with a different diagnostic framework. Functional neurological symptoms and functional or dissociative seizures involve their own clinical assessment pathways. One person can report features across several domains, but labels should not be assigned from isolated experiences.
Treatment: What Has Evidence, and What Remains Uncertain?
Treatment planning begins with confirming the diagnosis, addressing medical and substance-related contributors, understanding comorbid conditions, and clarifying goals that matter to the patient. Psychotherapy is widely used as the main clinical approach, with psychological education and individualized management of distress, avoidance, anxiety, and depressive symptoms. The clinical resources of Mayo Clinic describe talking therapies and adjunctive care. These practice descriptions should be interpreted alongside the research evidence rather than treated as proof that any named therapy is reliably curative.
The strongest broad synthesis available is Wang and colleagues' systematic review published in 2024. It included 41 studies involving just 300 participants, with four randomized controlled trials, one nonrandomized controlled trial, case series, and many case reports. The review covered several pharmacological, psychological, and neuromodulation approaches. Overall quantity and methodological quality were low. The correct conclusion is that clinicians have approaches to consider and adapt, while the field still lacks strong, reproducible comparative evidence establishing a clearly superior DPDR-specific intervention.
Cognitive behavioral therapy
A CBT formulation may address catastrophic interpretations of depersonalization, repetitive symptom checking, avoidance of ordinary activities, fear of losing control, and escalating anxiety. Techniques can involve education about the experience, attention training, graded return to avoided situations, work on interpretations, and strategies for responding more flexibly to symptoms. A small open CBT study involving 21 patients reported improvements and a subgroup no longer meeting diagnostic criteria by the end of treatment. Its uncontrolled design cannot establish how much change was caused by CBT instead of expectancy, passage of time, selection, or concurrent influences. Larger randomized comparisons remain important.
A subsequent randomized feasibility study published online in December 2025 directly compared CBT adapted for depersonalization-derealization disorder with treatment as usual in 30 adults in London NHS services. Only 63% completed the final assessment; the CBT group showed a larger mean reduction in Cambridge Depersonalization Scale scores (16.9 points versus 5.5 points), but variability was high and the trial was designed for feasibility rather than definitive efficacy. These results support undertaking larger, better-retained randomized trials, not a claim that CBT has already been established as superior treatment for every patient.
Other psychological treatments and supportive work
Psychodynamic therapy, integrative psychotherapy, and approaches tailored to trauma, anxiety, emotional processing, or functional impairment may be used according to the formulation. Some individuals benefit from developing language for the experience, restoring tolerable emotional engagement, working with interpersonal stressors, or reducing isolation. Research on the effectiveness of these interventions specifically for DPDR disorder is much thinner than for several more extensively studied mental-health conditions. It is especially important not to transfer trial results from PTSD or generalized anxiety wholesale to primary DPDR.
Medication
There is no medication with consistently established efficacy as a DPDR-specific treatment. Clinicians may prescribe medication for co-occurring depression, anxiety, panic, or another condition according to that condition's indications and the person's clinical needs. Medication studies targeting depersonalization itself have been small and inconsistent. A small placebo-controlled crossover trial of lamotrigine found no clear advantage over placebo; uncontrolled reports of add-on medication are not proof of effectiveness. One seemingly positive later lamotrigine trial is flagged in PubMed with a retraction notice and should not be used as positive efficacy evidence.
An open naltrexone trial and other small exploratory studies have generated hypotheses rather than routine treatment standards. These treatments have safety considerations and require individualized prescribing and monitoring. Readers should not start, stop, or combine prescription medications on the strength of a case series or online treatment discussion. A clinician can explain which drug is intended to treat which symptom or comorbid diagnosis, what evidence supports the decision, and how benefit and adverse effects will be evaluated.
Neuromodulation and newer approaches
Repetitive transcranial magnetic stimulation and other neuromodulation techniques have been explored in limited DPDR studies, sometimes alongside medication or psychotherapy. Small samples, differences in brain targets and protocols, and inconsistent outcome measures make these approaches investigational for disorder-specific effectiveness. A research clinic or specialist may discuss studies where appropriate; an online advertisement claiming a proven brain-reset intervention goes beyond the available evidence.
A Practical, Individualized Treatment Plan
A useful plan begins by stating the problems in observable terms: how often episodes happen, how strongly they interfere with work or relationships, whether the person avoids activities, how sleep is functioning, and what co-occurring symptoms need their own treatment. A clinician and patient can then identify priorities, establish a follow-up schedule, and track both symptoms and real-world participation. Progress may include fewer hours of preoccupation, a return to valued activities, reduced panic about episodes, or increased emotional presence, even before all symptoms disappear.
Good follow-up also asks whether an approach is making matters worse. Some exercises designed to increase attention to internal sensations may heighten distress in particular people, and trauma-focused interventions require appropriate assessment and pacing. Treatment should be adjusted to the person's reactions, preferences, medical history, and goals. Transparent discussion of uncertain evidence and potential harms is part of competent care.
What to Do During a Depersonalization or Derealization Episode
For someone with a familiar, previously assessed episode, the immediate goal is usually to respond safely and reduce escalation. They may find it useful to name what is happening in ordinary language, orient toward a known place and date, look at stable objects in the room, place their feet on the floor, or use a manageable sensory cue such as the texture of clothing or the feel of a chair. Attention can then be directed toward a simple external task or a conversation rather than repeated testing of whether everything feels normal. These strategies are practical supports, not proven stand-alone cures for DPDR.
Slow, comfortable breathing may help when panic or rapid breathing accompanies the episode, although intensive body-focused exercises can be unpleasant for some people. Individual responses differ. The aim is to select a low-risk response that restores functioning and does not intensify monitoring. Avoid driving or operating dangerous equipment if concentration, awareness, or coordination is affected. Episodes with unusual new symptoms, loss of consciousness, severe confusion, or possible intoxication require assessment rather than routine self-management.
Longer-term self-care may include consistent sleep, reduction of substance exposure, regular meals, manageable activity, social connection, and attention to patterns of stress or avoidance. None of these measures is a validated replacement for diagnostic evaluation or care in a severe persistent condition. Tracking symptoms can help a clinician when done briefly and purposefully; monitoring every sensation many times each hour may become another burden.
How Friends and Family Can Help
A person who feels detached often wants to be understood without being interrogated about whether the world is truly real. A supportive response can acknowledge that the sensations are frightening, invite the person to sit somewhere comfortable, offer calm company, and ask what has helped before. Loved ones can encourage an assessment when symptoms persist or interfere with life and support practical routines while respecting personal boundaries.
Repeated arguments about the unreality sensation, constant reassurance rituals, pressure to recount alleged forgotten trauma, and dramatic descriptions of what the experience 'must mean' can add confusion. The most useful practical focus is safety, continuity of care, and the person's own goals. Family support does not require assigning a diagnosis or accepting any one causal theory.
Course, Prognosis, and Recovery
DPDR disorder can have an episodic or prolonged course. Some people improve as stressors are addressed or with tailored care; others experience long periods of persistent or fluctuating symptoms. The available research cannot provide a reliable personal prediction such as a fixed number of weeks to recovery or a universal cure rate. Clinical severity, comorbid illness, substance exposure, stress context, access to care, and individual response may all shape the course, but prognostic research remains limited. The Cleveland Clinic clinical summary describes this variability.
Recovery is best discussed as a concrete clinical and personal process. A meaningful improvement can be less distress about depersonalization, more participation in everyday life, better emotional connection, restored social confidence, and episodes that become less intense or less frequent. Symptom persistence is an invitation to reassess the formulation and care plan, not evidence that change is impossible. When treatment fails, the next step is to review the diagnosis, medical and psychiatric comorbidity, suitability of the intervention, and tolerability rather than promise another unproven quick fix.
When to Seek Professional or Emergency Assessment
Arrange an appointment with a qualified health professional when the experience is recurrent, lasts beyond a brief episode, causes distress, disrupts relationships or work, or accompanies significant anxiety, depression, substance concerns, memory changes, or impaired functioning. A primary care clinician can help examine possible medical causes and refer to appropriate mental-health care. Describing onset, symptom examples, duration, frequency, and medication or substance changes is more useful than arriving with a self-assigned diagnosis.
Seek urgent medical help for first-time episodes with loss of consciousness, new seizures, major neurological deficits, severe new headache, significant head injury, sudden severe confusion, overdose, or another acute medical concern. Immediate local emergency assistance is appropriate for imminent danger of self-harm or inability to maintain safety. In the United States, the 988 Suicide & Crisis Lifeline can help with a mental-health crisis, while 911 or emergency medical services are for immediate life-threatening emergencies. These thresholds concern clinical safety, not a claim that DPDR itself inevitably produces dangerous behavior.
Frequently Asked Questions
Is depersonalization-derealization disorder the same as dissociation?
DPDR disorder is a specific dissociative diagnosis. Dissociation is a broader descriptive term for experiences involving altered integration or continuity of awareness, memory, identity, perception, or related functions. Many dissociative experiences are transient and never become a disorder. An independent diagnosis requires its defined clinical features and exclusions.
Can I experience derealization without depersonalization?
Yes. A person may report that the surrounding world feels unfamiliar or unreal while their sense of self remains relatively intact. Others experience depersonalization alone or a combination of both. The broader diagnosis can involve either symptom domain, provided the full clinical criteria are met.
Does feeling unreal mean I am developing psychosis?
The typical DPDR presentation includes insight that the feeling of unreality is subjective. Psychotic disorders are assessed through a wider pattern that may include changes in reality testing, delusional beliefs, hallucinations, and associated symptoms. A specific frightening sensation alone cannot establish either diagnosis. New, severe, or unusual experiences should be evaluated clinically.
Can anxiety or panic cause derealization?
Derealization and depersonalization can occur during panic attacks and periods of severe anxiety. Whether they also represent a separate DPDR disorder depends on persistence, impairment, insight, medical and substance factors, and the larger clinical picture. Treating panic symptoms may help where panic is a major contributor.
Can cannabis trigger depersonalization or derealization?
Cannabis exposure is associated with such experiences in some people, especially around intoxication or acute anxiety. Timing and other symptoms matter. A clinician should assess persistent symptoms that follow substance use and consider the range of possible contributing causes. Another person's account online is not a diagnostic template.
How long can DPDR symptoms last?
Transient symptoms can last minutes or hours. More persistent or recurring presentations may continue for days, weeks, months, or longer, sometimes with fluctuating intensity. Duration alone does not establish a disorder or predict an individual's future course. Assessment is appropriate when symptoms persist or interfere with normal life.
Is DPDR caused by childhood trauma?
Some studies and clinical histories connect DPDR with stressful or traumatic experiences, including childhood adversity, but no trauma history is necessary to recognize the symptom pattern. The symptoms do not prove a previously forgotten event, and memories emerging during treatment are not automatically independently verified historical evidence.
Can an online DPDR test diagnose me?
No. Questionnaires may help characterize symptoms or guide a discussion with a clinician, but they do not establish intact reality testing, clinically significant impairment, or exclusion of medical, substance-related, and alternative psychiatric conditions. A clinician makes the diagnostic judgment using interview and appropriate additional assessment.
Is there a medication that cures DPDR disorder?
No medication has consistently demonstrated specific efficacy for the disorder in a sufficiently strong evidence base. Prescriptions may be appropriate for separate diagnosed conditions or carefully considered specialist management. Positive anecdotes and uncontrolled studies cannot establish a reliable cure, and self-medication carries risks.
Can depersonalization-derealization disorder get better?
Improvement is possible, and clinical care can target distress, avoidance, anxiety, functional impairment, and other contributing conditions. There is no reliable universal timetable, and the research does not establish one treatment as uniformly effective. Personal follow-up and adjustment of the care plan are more useful than promises of a guaranteed recovery date.
Related Articles
Childhood Trauma and Dissociation: What Is the Connection? — evidence on an important associated history, with limits on causal inference.
Dissociative Subtype of PTSD: Depersonalization, Derealization, and Assessment — the PTSD-specific diagnostic pathway.
Posttraumatic Stress Disorder (PTSD): Symptoms, Diagnosis, and Treatment — broader PTSD criteria and management.
Neurosis vs Dissociation: Historical Concepts and Modern Diagnostic Categories — historical terminology and modern classification.
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing. Publisher resource.
Cleveland Clinic. (2023). Depersonalization-derealization disorder: Symptoms, causes, and treatment. Clinical resource.
Hunter, E. C. M., Sierra, M., & David, A. S. (2004). The epidemiology of depersonalisation and derealisation: A systematic review. Social Psychiatry and Psychiatric Epidemiology, 39(1), 9–18. https://doi.org/10.1007/s00127-004-0701-4.
Hunter, E. C. M., Baker, D., Phillips, M. L., Sierra, M., & David, A. S. (2005). Cognitive-behaviour therapy for depersonalisation disorder: An open study. Behaviour Research and Therapy, 43(9), 1121–1130. https://doi.org/10.1016/j.brat.2004.08.003.
Hunter, E. C. M., Ring, L., Gafoor, R., Morant, N., Lewis, G., Perkins, J., et al. (2025). Cognitive behavior therapy for depersonalization-derealization disorder (CBT-f-DDD): A feasibility randomized trial. Pilot and Feasibility Studies, 12, Article 9. https://doi.org/10.1186/s40814-025-01742-1.
Mayo Clinic. (2025a). Depersonalization-derealization disorder: Diagnosis and treatment. Clinical resource.
Mayo Clinic. (2025b). Depersonalization-derealization disorder: Symptoms and causes. Clinical resource.
Merck Manual Professional. Depersonalization/derealization disorder. Clinical reference.
Millman, L. S. M., Huang, X., Wainipitapong, S., Medford, N., & Pick, S. (2024). Behavioural, autonomic, and neural responsivity in depersonalisation-derealisation disorder: A systematic review of experimental evidence. Neuroscience & Biobehavioral Reviews, 163, Article 105783. https://doi.org/10.1016/j.neubiorev.2024.105783.
Shader, R. I., & Greenblatt, D. J. (2014). Editors' note: Retraction notice. Journal of Clinical Psychopharmacology, 34(6), 671. https://doi.org/10.1097/JCP.0000000000000243.
Sierra, M., & Berrios, G. E. (2000). The Cambridge Depersonalization Scale: A new instrument for the measurement of depersonalization. Psychiatry Research, 93(2), 153–164. https://pubmed.ncbi.nlm.nih.gov/10725532/.
Sierra, M., Phillips, M. L., Ivin, G., Krystal, J., & David, A. S. (2003). A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology, 17(1), 103–105. https://doi.org/10.1177/0269881103017001712.
Simeon, D., & Knutelska, M. (2005). An open trial of naltrexone in the treatment of depersonalization disorder. Journal of Clinical Psychopharmacology, 25(3), 267–270. https://pubmed.ncbi.nlm.nih.gov/15876908/.
Wainipitapong, S., Millman, L. S. M., Huang, X., Wieder, L., Terhune, D. B., & Pick, S. (2025). Assessing dissociation: A systematic review and evaluation of existing measures. Journal of Psychiatric Research, 181, 91–98. https://doi.org/10.1016/j.jpsychires.2024.11.040.
Wang, S., Zheng, S., Zhang, X., Ma, R., Feng, S., Song, M., Zhu, H., & Jia, H. (2024). The treatment of depersonalization-derealization disorder: A systematic review. Journal of Trauma & Dissociation, 25(1), 6–29. https://doi.org/10.1080/15299732.2023.2231920.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO. https://www.who.int/publications/i/item/9789240077263.
Yang, J., Millman, L. S. M., David, A. S., & Hunter, E. C. M. (2023). The prevalence of depersonalization-derealization disorder: A systematic review. Journal of Trauma & Dissociation, 24(1), 8–41. https://doi.org/10.1080/15299732.2022.2079796.